Skip to content
DefDex

Federal award

ROCHE DIAGNOSTICS CORPORATION

W91YTZ20P0288

Contract

Obligated and Ceiling

Obligated (net)
$538,127.74
Ceiling (potential value, not spending)
$538,127.74
Current value
$538,127.74
Gross positive obligations
$538,127.74

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ROCHE HOLDING AG · WJHDT127L353
Awarding agency
Department of War · sub-agency 2100 · office W91YTZ
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W91YTZ20P0288
Award type code
B
Actions
13 · Sep 21, 2020 to Jun 8, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History13

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 8, 2026FY2026P00012M$0.00
—
Oct 28, 2024FY2025P00011C$112,671.82
—
Sep 3, 2024FY2024P00010G$0.00
—
Nov 27, 2023FY2024P00009C$109,390.82
—
Sep 19, 2023FY2023P00008C$6,642.00
—
Sep 11, 2023FY2023P00007G$0.00
—
Nov 4, 2022FY2023P00006C$106,204.44
—
Jun 16, 2022FY2022P00005G$0.00
—
Jan 28, 2022FY2022P00004M$0.00
—
Oct 12, 2021FY2022P00003C$103,111.38
—
Aug 16, 2021FY2021P00002G$0.00
—
Nov 17, 2020FY2021P00001C$100,107.28
—
Sep 21, 2020FY20200—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.